1. Home
  2. OGEN vs BDRX Comparison

OGEN vs BDRX Comparison

Compare OGEN & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGEN
  • BDRX
  • Stock Information
  • Founded
  • OGEN 1996
  • BDRX 2000
  • Country
  • OGEN United States
  • BDRX United Kingdom
  • Employees
  • OGEN N/A
  • BDRX N/A
  • Industry
  • OGEN Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OGEN Health Care
  • BDRX Health Care
  • Exchange
  • OGEN Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • OGEN 9.8M
  • BDRX 9.6M
  • IPO Year
  • OGEN N/A
  • BDRX N/A
  • Fundamental
  • Price
  • OGEN $1.14
  • BDRX $0.99
  • Analyst Decision
  • OGEN
  • BDRX Strong Buy
  • Analyst Count
  • OGEN 0
  • BDRX 1
  • Target Price
  • OGEN N/A
  • BDRX $8.00
  • AVG Volume (30 Days)
  • OGEN 131.0K
  • BDRX 3.6M
  • Earning Date
  • OGEN 08-12-2024
  • BDRX 04-19-2024
  • Dividend Yield
  • OGEN N/A
  • BDRX N/A
  • EPS Growth
  • OGEN N/A
  • BDRX N/A
  • EPS
  • OGEN N/A
  • BDRX N/A
  • Revenue
  • OGEN $20,629.00
  • BDRX $482,278.00
  • Revenue This Year
  • OGEN N/A
  • BDRX N/A
  • Revenue Next Year
  • OGEN N/A
  • BDRX N/A
  • P/E Ratio
  • OGEN N/A
  • BDRX N/A
  • Revenue Growth
  • OGEN N/A
  • BDRX N/A
  • 52 Week Low
  • OGEN $0.97
  • BDRX $0.67
  • 52 Week High
  • OGEN $7.74
  • BDRX $9.64
  • Technical
  • Relative Strength Index (RSI)
  • OGEN 40.97
  • BDRX 51.90
  • Support Level
  • OGEN $1.00
  • BDRX $0.91
  • Resistance Level
  • OGEN $1.19
  • BDRX $1.66
  • Average True Range (ATR)
  • OGEN 0.07
  • BDRX 0.13
  • MACD
  • OGEN 0.03
  • BDRX 0.02
  • Stochastic Oscillator
  • OGEN 61.11
  • BDRX 29.40

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: